PETALING JAYA: TMC Life Sciences Bhd remains optimistic about its earnings outlook for the year, banking on its core competency of women and children healthcare services.
TMC group chief executive officer Nadiah Wan said the tertiary medical services provided at its flagship hospital, Thomson Hospital Kota Damansara, have contributed to the strong growth in revenue per bed.
“The hospital business is stable and occupancy rate is reaching maximum levels.
“This peak performance of the hospital’s operations has allowed us to better optimise our resources and introduce new services.
“Going forward, we plan to look into introducing specific tertiary medical services like women’s health and oncology, as well as men’s health, in areas like infertility,” she told a media briefing here yesterday.
In the past year, TMC has added a range of tertiary medical services, which include haematology, rheumatology, acute stroke team with neurology, neurosurgery and neuro-radiology, cardiothoracic surgery, intensive care, as well as bariatric surgery.
The construction of the new blocks at Thomson Hospital Kota Damansara is currently 12% completed and due to be operational in early 2021.
This will increase the hospital’s number of beds from 205 to 600.
TMC’s other project, Thomson Iskandar Medical Hub in Vantage Bay, Johor Baru, has commenced piling work and is on track for completion in the first quarter of 2024.
Meanwhile, the group’s other business segment, TMC Fertility, continued to see growing numbers in local and foreign patients.
An estimated 30% to 50% of TMC Fertility’s patients are foreigners from Indonesia, China and Singapore, given the ideal location of its centres in Penang, the Klang Valley and Johor Baru.
“We are mulling plans to establish a fertility centre in Sabah and Sarawak Malaysia, probably Kuching. However, we have yet to identify a suitable partner and location for the centre – we are still in talks with several parties,” Nadiah added.
TMC registered a 30.4% year-on-year (y-o-y) increase in net profit to RM6.2mil for the second quarter ended Feb 28, 2019, bringing its net profit for the first half to RM13.28mil.
The improved net profit during the quarter was mainly driven by optimisation of resources.
TMC also achieved a healthy earnings before interest, tax, depreciation and amortisation margin of 22% in the first-half of financial year 2019 (FY19), on the back of increased patient load and a higher intensity of case mix.
Outpatient attendance in the first-half of FY19 grew 3% y-o-y to 72,543, while inpatient admission increased 5% y-o-y to 10,946.